Drug Design Approaches to Manipulate the Agonist-Antagonist Equilibrium in Steroid Receptors

QR Code

Drug Design Approaches to Manipulate the Agonist-Antagonist Equilibrium in Steroid Receptors

None

Saved in:

Bibliographic Details
Main Authors:	Lusher, Scott J., Conti, Paolo, Dokter, Wim, Hermkens, Pedro H., Vlieg, Jacob de
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/25418
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PROSPECTS OF Toll-LIKE RECEPTOR AGONISTS AND ANTAGONISTS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS
by: A. A. Nikonova, et al.
Published: (2019-07-01)

INVERSE AGONISTS: MORE THAN JUST ANTAGONISTS?
by: R. N. Alyautdin, et al.
Published: (2022-06-01)

Agonist-antagonist muscular co-contraction improves rapid corrective responses
by: Daniel P. Armstrong, et al.
Published: (2025-08-01)

The GABAА receptors agonists and antagonists influence on formation of a latent inhibition at rats with different levels of anxiety
by: A. V. Redkina, et al.
Published: (2012-02-01)

The role of agonistic/antagonistic activity in the development of psychotropic effects of antipsychotics
by: V. I. Kozlovskiy, et al.
Published: (2019-05-01)

The role of cannabinoid agonists and antagonists on folliculogenesis and evolutionary events in the mouse ovary
by: Vida Mirzaie, et al.
Published: (2025-09-01)

Steroid Receptors in Renal Cell Carcinoma
by: Yakirevich, Evgeny, et al.
Published: (2012)

ANGIOTENSIN RECEPTOR ANTAGONISTS: GOING WITH THE TIMES
by: E. O. Taratukhin
Published: (2013-06-01)

Difficult choice: angiotensin receptor antagonists
by: E. O. Taratukhin
Published: (2013-04-01)

Current Application of Mineralocorticoid Antagonist (MRA) in Heart Failure and CKD: Does Non-Steroidal Drug Add Novel Insights
by: Irene Carlino, et al.
Published: (2025-07-01)

Place of imidazoline receptor agonists in the treatment of hypertension
by: D. V. Nebieridze, et al.
Published: (2022-01-01)

Imidazoline receptor agonists and left ventricular hypertrophy
by: L. L. Kirichenko, et al.
Published: (2005-04-01)

Metabolic syndrome and angiotensin II receptor antagonists
by: K. M. Mamyrbayeva, et al.
Published: (2007-04-01)

Place of imidazoline receptor agonists in the treatment of arterial hypertension
by: D. V. Nebieridze, et al.
Published: (2023-12-01)

HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER
by: K. M. Nyushko, et al.
Published: (2015-01-01)

Functional Protein Interactions in Steroid Receptor-Chaperone Complexes
by: Ratajczak, Thomas, et al.
Published: (2012)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND NEPHROPROTECTION: PLACE OF OLMESARTAN
by: V. V. Fomin
Published: (2013-08-01)

AT II RECEPTOR ANTAGONISTS IN CHRONIC HEART FAILURE TREATMENT
by: M. A. Gurevich
Published: (2009-04-01)

Side Effects of Steroidal And Non-Steroidal Anti-Inflammatory Drugs on The Oral Cavity.
by: Shayma Ghazi, et al.
Published: (2024-03-01)

Imidazoline receptor agonists: more than blood pressure reduction?
by: D. V. Nebieridze, et al.
Published: (2006-04-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia
by: S. G. Zakharov, et al.
Published: (2024-04-01)

Theory and practice of selective imidazoline receptor agonist use in Russia
by: N. I. Gaponova, et al.
Published: (2024-07-01)

PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET
by: L. V. Egshatyan, et al.
Published: (2015-09-01)

OPPORTUNITIES FOR OPTIMIZATION OF DRUG THERAPY BY ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AND ATRIAL SEPTOSTOMY
by: V. V. Gramovich, et al.
Published: (2018-12-01)

THE USE OF MINERALOCORTICOID RECEPTOR ANTAGONISTS IN THE PRE VENTION OF ATRIAL FIBRILLATION
by: N. T. Vatutin, et al.
Published: (2019-07-01)

Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy
by: S. R. Gilyarevsky, et al.
Published: (2023-10-01)

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016-01-01)

A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE
by: B. B. Gegenava, et al.
Published: (2015-09-01)

Place of agonists Imidazol(in)e Receptors in arterial hypertension patients therapy
by: A. N. Britov, et al.
Published: (2006-02-01)

Inhibition of Advanced Prostate Cancer by Androgens and Liver X Receptor Agonists
by: Chuu, Chih-Pin, et al.
Published: (2011)

Opioid Kappa Receptor Selective Agonist TRK-820 (Nalfurafine Hydrochloride)
by: Fujii, Hideaki, et al.
Published: (2012)

Glucagon-like peptide-1 receptor agonists: Prospects for use in rheumatology
by: Е. L. Nasonov, et al.
Published: (2024-04-01)

Emerging concepts in obesity management: focus on glucagon receptor agonist combinations
by: Sarah L Anderson
Published: (2025-07-01)

Bitter taste receptor agonists induce vasorelaxation in porcine coronary arteries
by: Ching-Chung Tsai, et al.
Published: (2025-07-01)

GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
by: Giulia Migliorisi, et al.
Published: (2025-07-01)

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?
by: D. V. Nebieridze, et al.
Published: (2015-12-01)

Management of Nephrotic Syndrome in Pediatric Patients Treated by Different Steroid Regimens
by: Valeria Chirico, et al.
Published: (2025-07-01)

ENDOTHELIUM RECEPTOR ANTAGONISTS IN PULMONARY ARTERIAL HYPERTENSION: YESTERDAY, TODAY, AND TOMORROW
by: T. V. Martynuk, et al.
Published: (2009-08-01)

Angiotensin II receptor antagonists – we have moved closer to the patient
by: L. G. Ratova, et al.
Published: (2005-04-01)